# Protagenic Therapeutics, Inc.\\new — Form D

Protagenic Therapeutics, Inc.\new of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-23. The offering totals $5.5M, of which $3.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2016-02-23
- Form: D
- Accession: 0001209191-16-101173
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $3.5M
- Remaining: $2.0M
- Investors: 22
- Date of first sale: 2016-02-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-257945

## Issuer

- Name: Protagenic Therapeutics, Inc.\\new
- CIK: 0001022899
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Phone: 212-994-8200

## Officers, directors & promoters (18)

| Name | Role | Location |
| --- | --- | --- |
| Robert H Ziroyan | Executive Officer | New York, NY |
| Mark Dyne | Director | Sherman Oaks, CA |
| Raymond Musci | Director | Sherman Oaks, CA |
| Raymond Musci | Executive Officer | Sherman Oaks, CA |
| Garo H Armen | Director | New York, NY |
| Garo H Armen | Executive Officer | New York, NY |
| Robert B Stein | Director | New York, NY |
| Alexander K Arrow | Executive Officer | New York, NY |
| Joshua B Silverman | Director | New York, NY |
| Brian J Corvese | Director | New York, NY |
| Khalil B Barrage | Director | New York, NY |
| Joshua K Silverman | Director | New York, NY |
| Gregory H Ekizian | Director | New York, NY |
| Lawrence Burstein | Director | NEW YORK, NY |
| Jerome Chazen | Director | New York, NY |
| Stuart Goldfarb | Director | New York, NY |
| Stuart Goldfarb | Executive Officer | New York, NY |
| Thomas Plotts | Executive Officer | New York, NY |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-12-23](https://search.stillhousedata.com/formd/0001493152-19-019605) | D/A | $2.5M | $670K |
| [2019-12-05](https://search.stillhousedata.com/formd/0001493152-19-018758) | D/A | $2.5M | $555K |
| [2019-10-29](https://search.stillhousedata.com/formd/0001493152-19-016091) | D | $2.5M | — |
| [2016-04-22](https://search.stillhousedata.com/formd/0001144204-16-095773) | D/A | $5.5M | $5.1M |
| [2016-04-22](https://search.stillhousedata.com/formd/0001144204-16-095771) | D/A | $5.5M | $4.6M |
| [2011-06-15](https://search.stillhousedata.com/formd/0001144204-11-035942) | D | $5.3M | $5.3M |

## More

- [CIK 1022899 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1022899&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001209191-16-101173.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.